Polycystic Kidney Disease
Polycystic kidney disease (PKD) is characterized by the presence of fluid-filled cysts in the kidneys. It is the fourth most common cause of chronic renal insufficiency or end-stage kidney disease. This book focuses on the basic and clinical aspects of the burgeoning PKD research under three section...
Gespeichert in:
| Weitere Verfasser: | |
|---|---|
| Format: | Elektronisch Buchkapitel |
| Sprache: | Englisch |
| Veröffentlicht: |
Australia
Exon Publications
2015
|
| Schlagworte: | |
| Online-Zugang: | DOAB: download the publication DOAB: description of the publication |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
MARC
| LEADER | 00000naaaa2200000uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_81824 | ||
| 005 | 20220521 | ||
| 003 | oapen | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 20220521s2015 xx |||||o ||| 0|eng d | ||
| 020 | |a codon.pkd.2015 | ||
| 020 | |a 9780994438102 | ||
| 040 | |a oapen |c oapen | ||
| 024 | 7 | |a 10.15586/codon.pkd.2015 |c doi | |
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a MJR |2 bicssc | |
| 100 | 1 | |a Li, Xiaogang |4 edt | |
| 700 | 1 | |a Li, Xiaogang |4 oth | |
| 245 | 1 | 0 | |a Polycystic Kidney Disease |
| 260 | |a Australia |b Exon Publications |c 2015 | ||
| 300 | |a 1 electronic resource (488 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a Polycystic kidney disease (PKD) is characterized by the presence of fluid-filled cysts in the kidneys. It is the fourth most common cause of chronic renal insufficiency or end-stage kidney disease. This book focuses on the basic and clinical aspects of the burgeoning PKD research under three sections. Section 1 provides a comprehensive guide to the diagnosis, management and treatment of PKD. Section 2 covers most of the fundamental molecular and cellular mechanisms underlying PKD, and how this knowledge is contributing to the development of potential novel therapeutic agents. Finally, section 3 focuses on extra-renal or secondary complications of PKD. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by-nc-nd/4.0/ |2 cc |4 https://creativecommons.org/licenses/by-nc-nd/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a MJR |2 bicssc | |
| 653 | |a Polycystic kidney disease | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://exonpublications.com/index.php/exon/issue/view/4 |7 0 |z DOAB: download the publication |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/81824 |7 0 |z DOAB: description of the publication |